Scientific Rigor
Mechanistic research and disciplined validation underpin every technology and program decision.
The Company
Science-Led. Translation-Focused.
Founded by Stanford scientists, N1 Life connects peptide engineering with human biology and product development. Our work starts with skin.
How We Work
Rigor at every stage.
Peptide engineering, human biology, and translational development shape our work. Human data connects each design decision to the next.
Human Data Intelligence
Proprietary, high-dimensional human tissue data informs carrier design, predictive models, and program development.
Translational Execution
Cross-functional expertise connects peptide engineering with clinical and product development.
Scientific Founders
Chemistry at the foundation.
Meet the founders behind N1 Life’s work in peptide engineering and precision delivery.
Co-Founder & CEO
Xiaoyu Zang (Janice), PhD
A Stanford-trained chemist working across synthetic chemistry, nanotechnology, and drug delivery.
Contact Us
Co-Founder & Director of Scientific Advisory Board
Paul Wender, PhD
His research spans synthetic and medicinal chemistry, cell-penetrating peptides, and delivery-system design.
Contact UsOur Approach
Precision delivery, built through learning.
N1 advances selected therapeutic and consumer health programs. The active, tissue, and development need guide where we focus.
Skin First
Skin combines a demanding biological barrier with accessible tissue and measurable outcomes. It is N1’s primary development focus.
Explore Our ProgramsLearning From Human Data
Consumer health and therapeutic programs inform the next delivery design. Each therapeutic program follows its own validation path.
Explore the ScienceWork With N1
Bring science into the conversation.
Talk with N1 about precision delivery and your development goals.